CDISC SDTM SDSP-002-03 CURRENT ISS - Relapsed or Refractory Peripheral T-Cell ADaM v2.1 / ADaM IG 1.0 Terminology Lymphoma - Interim Analysis 1 SDSP-002-04 2015-06-26 SDSP-002-05 ADaM SDSP-002-06 MedDRA define.xml 2.0 SDSP-002-07 (Adverse Events) SDSP-002-08 18.1 SDSP-002-09 WHO-DD SDSP-002-10 (Medications) 2015-03 SDSP-002-08 PLANNED ISE - Relapsed or Refractory Peripheral T-Cell ADaM v2.1 / SDTM ADaM IG 1.0 Terminology Lymphoma - Interim Analysis 1 SDSP-002-10 2015-06-26 ADaM MedDRA define.xml 2.0 (Adverse Events) 18.1 WHO-DD (Medications) 2015-03
SDSP-002-03 SDSP-002-04 SDSP-002-05 SDSP-002-06 SDSP-002-07 SDSP-002-08 SDSP-002-09 SDSP-002-10 CURRENT ISS - Relapsed or Refractory Peripheral T-Cell Lymphoma - Interim Analysis 1 ADaM v2.1 / ADaM IG 1.0 ADaM define.xml 2.0 CDISC SDTM Terminology 2015-06-26 MedDRA (Adverse Events) 18.1 WHO-DD (Medications) 2015-03 SDSP-002-08 SDSP-002-10 PLANNED ISE - Relapsed or Refractory Peripheral T-Cell Lymphoma - Interim Analysis 1 ADaM v2.1 / ADaM IG 1.0 ADaM define.xml 2.0 SDTM Terminology 2015-06-26 MedDRA (Adverse Events) 18.1 WHO-DD (Medications) 2015-03
SDSP_Example_Oncology.docx